Sanger sequencing, a foundational DNA sequencing technique, finds applications across diverse fields. Its precise base-by-base analysis is vital in genomics, genetic research, and diagnostics. Key features of sanger sequencing include accuracy, enabling identification of genetic variations and mutations, essential for disease diagnosis and forensics. It aids in DNA sequencing, studying gene function, and validating NGS data. Sanger sequencing also plays a role in vaccine development, pharmaceutical research, and evolutionary biology. Its versatility and reliability continue to drive advancements in biological sciences and personalized medicine.
According to Data Bridge Market Research, the Global Sanger Sequencing Market accounted for USD 1.92 billion in 2021 and is expected to reach a value of USD 7.47 billion by 2029. The market is expected to grow with a CAGR of 18.50% in the forecast period of 2022 to 2029.
“Technological advancements boost the market’s growth”
Technological advancements are driving the growth of the sanger sequencing market by continually improving sequencing accuracy, speed, and cost-efficiency. Innovations like automated sample preparation, capillary electrophoresis, and next-generation sequencing integration have made Sanger sequencing more accessible for research, clinical diagnostics, and personalized medicine. This expansion in application areas and increased adoption across industries are propelling market growth, as scientists and clinicians rely on Sanger sequencing for a wide range of genetic analyses, further advancing our understanding of genomics and its practical applications.
What restraints the growth of the global sanger sequencing market?
“Strict regulatory restrictions restraints the market’s growth”
Strict regulatory restrictions can hinder the growth of the sanger sequencing market. Compliance with rigorous quality control and data validation standards is essential in genomics and clinical applications. These regulations increase the cost and time required for development and approval, limiting market entry and growth. Additionally, stringent privacy and ethical guidelines regarding genetic data use and storage pose challenges. Such barriers can slow down innovation and adoption of Sanger sequencing technologies, impacting their market expansion in research, diagnostics, and healthcare sectors.
Segmentation: Global Sanger Sequencing Market
The global sanger sequencing market is segmented on the basis of application, sequencing, laboratory, research, and end use.
- On the basis of application, the sanger sequencing market is segmented into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, forensics, and others.
- On the basis of sequencing, the sanger sequencing market is segmented into shotgun sequencing, targeted gene sequencing, and others.
- On the basis of laboratory, the sanger sequencing market is segmented into wet labs, dry labs.
- On the basis of research, the sanger sequencing market is segmented into in-house, outsourced.
- On the basis of end use, the sanger sequencing market is segmented into academic and government research institutes, pharmaceutical companies, biotechnology companies, and hospitals and clinics.
Regional Insights: North America dominates the Global Sanger Sequencing Market
North America dominates the sanger sequencing market due to the increasing geriatric population, coupled with the widespread adoption of innovative medical technologies, which is driving growth in the healthcare sector. Older individuals typically require more healthcare services, while technological advancements enhance diagnosis, treatment, and patient care, resulting in a higher demand for medical equipment and services across various healthcare subsectors.
Asia-Pacific (APAC) is predicted to observe notable germination in the forecast period of 2022 to 2029, due to the increasing utilization of Sanger sequencing, which is catalysing advancements in genomics and related fields. This is fostering innovation, leading to more applications for Sanger sequencing technology. The expanded scope of research and development activities is propelling the Sanger sequencing market by creating new opportunities and driving demand for sequencing services and equipment.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-sanger-sequencing-market
The Prominent Key Players Operating in the Global Sanger Sequencing Market Include:
- Thermo Fisher Scientific Inc (U.S.)
- Source BioScience (U.K.)
- GenScript (U.S.)
- LGC Limited (U.K.)
- CeMIA (U.S.),
- Quintara Biosciences (U.S.)
- GenHunter Corporation (U.S.)
- GENEWIZ (U.S.), Nucleics (U.K.)
- SciGenom Labs Pvt. Ltd (India)
- Microsynth AG (Switzerland)
- Eurofins Scientific (Luxembourg)
- LGC Limited (U.K.)
- Fasteris SA (Switzerland)
- StarSEQ GmbH (Germany)
Above are the key players covered in the report, to know about more and exhaustive list of global sanger sequencing market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Sanger Sequencing Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
